Stock Analysts’ updated eps estimates for Friday, September 8th:

Ashtead Group plc (LON:AHT) had its buy rating reaffirmed by analysts at Liberum Capital. Liberum Capital currently has a GBX 1,940 ($25.05) target price on the stock.

Aviva plc (LON:AV) had its buy rating reissued by analysts at Jefferies Group LLC. They currently have a GBX 606 ($7.83) price target on the stock.

Anglesey Mining Plc (LON:AYM) had its speculative buy rating reiterated by analysts at Beaufort Securities.

AstraZeneca plc (LON:AZN) had its neutral rating reaffirmed by analysts at J P Morgan Chase & Co.

Benchmark Holdings PLC (LON:BMK) had its under review rating reiterated by analysts at Numis Securities Ltd.

Bovis Homes Group plc (LON:BVS) had its neutral rating reaffirmed by analysts at J P Morgan Chase & Co.

Circassia Pharmaceuticals PLC (LON:CIR) had its neutral rating reaffirmed by analysts at J P Morgan Chase & Co.

Capita PLC (LON:CPI) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a GBX 750 ($9.69) target price on the stock.

Fenner plc (LON:FENR) had its neutral rating reaffirmed by analysts at J P Morgan Chase & Co.

Greene King plc (LON:GNK) had its buy rating reissued by analysts at Shore Capital.

Greene King plc (LON:GNK) had its add rating reiterated by analysts at Peel Hunt. They currently have a GBX 750 ($9.69) target price on the stock.

Go-Ahead Group plc (LON:GOG) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a GBX 2,425 ($31.32) target price on the stock.

GlaxoSmithKline plc (LON:GSK) had its neutral rating reaffirmed by analysts at Citigroup Inc.. Citigroup Inc. currently has a GBX 1,700 ($21.96) target price on the stock.

ObsEva SA (NASDAQ:OBSV) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman’s reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland. “

Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $49.00 target price on the stock. According to Zacks, “Ollie’s Bargain Outlet Holdings, Inc. is a retailer of closeouts, excess inventory and salvage merchandise. The Company’s product includes housewares, food, books and stationery, bed and bath, floor coverings, toys and hardware. Its brand portfolio consist of Ollie’s, Ollie’s Bargain Outlet, Ollie’s Army, Real Brands! Real Bargains! and Good Stuff Cheap. The company operates primarily in Alabama, Delaware, Georgia, Indiana, Kentucky, Maryland, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia. Ollie’s Bargain Outlet Holdings, Inc. is based in Harrisburg, United States. “

Perry Ellis International (NASDAQ:PERY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $25.00 price target on the stock. According to Zacks, “Perry Ellis International, Inc. is a leading designer, distributor and licensor of a broad line of high quality men’s and women’s apparel, accessories, and fragrances. The company’s collection of dress and casual shirts, golf sportswear, sweaters, dress and casual pants and shorts, jeans wear, active wear and men’s and women’s swimwear is available through all major levels of retail distribution. The company, through its wholly owned subsidiaries, owns a portfolio of nationally and internationally recognized brands including Perry Ellis, Jantzen, Cubavera, Munsingwear, Savane, Original Penguin, Grand Slam, Natural Issue, Pro Player, the Havanera Co., Axis, Tricots St. Raphael, Gotcha, Girl Star and MCD. The company enhances its roster of brands by licensing trademarks from third parties including Dockers for outerwear, Nike and JAG for swimwear, and PING and PGA TOUR for golf apparel. “

Petrofac Limited (LON:PFC) had its buy rating reiterated by analysts at Societe Generale. Societe Generale currently has a GBX 530 ($6.84) target price on the stock.

PRA Health Sciences (NASDAQ:PRAH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $87.00 price target on the stock. According to Zacks, “PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina. “

Party City Holdco (NYSE:PRTY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $16.00 price target on the stock. According to Zacks, “Party City Holdco Inc. is involved in designs, manufactures, contracts for manufacture and distributes party goods, including paper and plastic tableware, metallic and latex balloons, Halloween and other costumes, accessories, novelties, gifts and stationery. It also operates specialty retail party supply stores primarily in the United States and Canada. Party City Holdco Inc. is based in Elmsford, New York. “

Pearson plc (LON:PSON) had its sell rating reissued by analysts at Liberum Capital. Liberum Capital currently has a GBX 330 ($4.26) price target on the stock.

Remy Cointreau Unspon (NASDAQ:REMYY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $13.00 target price on the stock. According to Zacks, “Remy Cointreau SA is an operator of Wine & Spirits market. The company’s portfolio consists of Rémy Martin and Louis XIII cognacs, the Cointreau liqueur as well as the Metaxa, Mount Gay, St-Rémy, Bruichladdich, Port Charlotte, Octomore and The Botanist spirits. Remy Cointreau SA is headquartered in Cognac, France. “

Revance Therapeutics (NASDAQ:RVNC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $28.00 target price on the stock. According to Zacks, “Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance’s science is based upon a proprietary TransMTS® peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance’s initial focus is on developing daxibotulinumtoxinA, the company’s highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company’s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform. “

Sanmina Corporation (NASDAQ:SANM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sanmina Corporation is engaged in providing electronics contract manufacturing services. It focuses on engineering and fabricating complex components and also on providing complete end-to-end supply chain solutions to Original Equipment Manufacturers. The Company’s services include product design and engineering, including initial development, detailed design, prototyping, validation, preproduction services and manufacturing design release; manufacturing of components, subassemblies and complete systems; final system assembly and test; direct order fulfillment and logistics services, and after-market product service and support. Sanmina Corporation, formerly known as Sanmina-SCI Corp., is based in San Jose, California. “

SecureWorks Corp. (NASDAQ:SCWX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “SecureWorks Corp. offers intelligence-driven information security solutions focused on protecting from cyber-attacks. The Company’s solutions enable organizations to fortify their cyber defenses to prevent security breaches; detect malicious activity in real time; prioritize and respond rapidly to security breaches and predict emerging threats. Its integrated suite of solutions include managed security, threat intelligence, security and risk consulting as well as incident response. SecureWorks Corp. is based in Atlanta, Georgia. “

Seeing Machines Limited (LON:SEE) had its corporate rating reiterated by analysts at FinnCap. FinnCap currently has a GBX 12 ($0.15) target price on the stock.

TBC Bank Group PLC (LON:TBCG) had its buy rating reissued by analysts at Peel Hunt. They currently have a GBX 2,000 ($25.83) price target on the stock.

Trinity Mirror plc (LON:TNI) had its buy rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 190 ($2.45) target price on the stock.

ValiRx Plc (LON:VAL) had its speculative buy rating reiterated by analysts at Beaufort Securities. Beaufort Securities currently has a GBX 6.50 ($0.08) target price on the stock.

Venture Life Group PLC (LON:VLG) had its speculative buy rating reaffirmed by analysts at Beaufort Securities.

Receive News & Ratings for Ashtead Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashtead Group plc and related companies with MarketBeat.com's FREE daily email newsletter.